Chmiel JF - Search Results

1

Considerations for the Conduct of Clinical Trials with Antiinflammatory Agents in Cystic Fibrosis. A Cystic Fibrosis Foundation Workshop Report.

Torphy TJ, Allen J, Cantin AM, Konstan MW, Accurso FJ, Joseloff E, Ratjen FA, Chmiel JF; Antiinflammatory Therapy Working Group. Torphy TJ, et al. Among authors: chmiel jf. Ann Am Thorac Soc. 2015 Sep;12(9):1398-406. doi: 10.1513/AnnalsATS.201506-361OT. Ann Am Thorac Soc. 2015. PMID: 26146892 Review.

2

Pitfall in the use of genotype analysis as the sole diagnostic criterion for cystic fibrosis.

Chmiel JF, Drumm ML, Konstan MW, Ferkol TW, Kercsmar CM. Chmiel JF, et al. Pediatrics. 1999 Apr;103(4 Pt 1):823-6. doi: 10.1542/peds.103.4.823. Pediatrics. 1999. PMID: 10103316

3

IL-10 attenuates excessive inflammation in chronic Pseudomonas infection in mice.

Chmiel JF, Konstan MW, Knesebeck JE, Hilliard JB, Bonfield TL, Dawson DV, Berger M. Chmiel JF, et al. Am J Respir Crit Care Med. 1999 Dec;160(6):2040-7. doi: 10.1164/ajrccm.160.6.9901043. Am J Respir Crit Care Med. 1999. PMID: 10588626

4

Murine models of CF airway infection and inflammation.

Chmiel JF, Konstan MW, Berger M. Chmiel JF, et al. Methods Mol Med. 2002;70:495-515. doi: 10.1385/1-59259-187-6:495. Methods Mol Med. 2002. PMID: 11917546 No abstract available.

5

Prolonged inflammatory response to acute Pseudomonas challenge in interleukin-10 knockout mice.

Chmiel JF, Konstan MW, Saadane A, Krenicky JE, Lester Kirchner H, Berger M. Chmiel JF, et al. Am J Respir Crit Care Med. 2002 Apr 15;165(8):1176-81. doi: 10.1164/ajrccm.165.8.2107051. Am J Respir Crit Care Med. 2002. PMID: 11956064

6

The role of inflammation in the pathophysiology of CF lung disease.

Chmiel JF, Berger M, Konstan MW. Chmiel JF, et al. Clin Rev Allergy Immunol. 2002 Aug;23(1):5-27. doi: 10.1385/CRIAI:23:1:005. Clin Rev Allergy Immunol. 2002. PMID: 12162106 Review.

7

Inflammatory and microbiologic markers in induced sputum after intravenous antibiotics in cystic fibrosis.

Ordoñez CL, Henig NR, Mayer-Hamblett N, Accurso FJ, Burns JL, Chmiel JF, Daines CL, Gibson RL, McNamara S, Retsch-Bogart GZ, Zeitlin PL, Aitken ML. Ordoñez CL, et al. Among authors: chmiel jf. Am J Respir Crit Care Med. 2003 Dec 15;168(12):1471-5. doi: 10.1164/rccm.200306-731OC. Epub 2003 Sep 11. Am J Respir Crit Care Med. 2003. PMID: 12969869 Clinical Trial.

8

State of the art: why do the lungs of patients with cystic fibrosis become infected and why can't they clear the infection?

Chmiel JF, Davis PB. Chmiel JF, et al. Respir Res. 2003;4(1):8. doi: 10.1186/1465-9921-4-8. Epub 2003 Aug 27. Respir Res. 2003. PMID: 14511398 Free PMC article. Review.

9

Anti-inflammatory medications for cystic fibrosis lung disease: selecting the most appropriate agent.

Chmiel JF, Konstan MW. Chmiel JF, et al. Treat Respir Med. 2005;4(4):255-73. doi: 10.2165/00151829-200504040-00004. Treat Respir Med. 2005. PMID: 16086599 Review.

10

Inflammation and anti-inflammatory therapies for cystic fibrosis.

Chmiel JF, Konstan MW. Chmiel JF, et al. Clin Chest Med. 2007 Jun;28(2):331-46. doi: 10.1016/j.ccm.2007.02.002. Clin Chest Med. 2007. PMID: 17467552 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

83 results

Search Page

Filters